Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NKCC1 inhibitors(Solute carrier family 12 member 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H25F3N2O4S |
InChIKeyZAJDYPRGNPKHEI-UHFFFAOYSA-N |
CAS Registry2497525-96-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Down Syndrome | Preclinical | IT | 01 Aug 2020 |